Top 10 Medical Stocks To Buy Right Now

tags:STNG,RRD,NBR,THO,ROK,JKE,JE,USA,NMKEF,AMBA,

Amarin (NASDAQ: AMRN) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

Analyst Ratings

Get Amarin alerts:

This is a breakdown of current ratings and recommmendations for Amarin and Aptevo Therapeutics, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amarin 0 0 3 0 3.00 Aptevo Therapeutics 0 0 2 0 3.00

Amarin presently has a consensus target price of $9.00, indicating a potential upside of 193.16%. Aptevo Therapeutics has a consensus target price of $10.50, indicating a potential upside of 93.37%. Given Amarin’s higher probable upside, equities research analysts clearly believe Amarin is more favorable than Aptevo Therapeutics.

Top 10 Medical Stocks To Buy Right Now: Scorpio Tankers Inc.(STNG)

Advisors' Opinion:

• [By Lisa Levin]

  Wednesday afternoon, the energy shares gained 0.74 percent. Meanwhile, top gainers in the sector included Pengrowth Energy Corporation (NYSE: PGH), up 12 percent, and Scorpio Tankers Inc. (NYSE: STNG), up 12 percent.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Scorpio Tankers (STNG)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Paul Ausick]

  Scorpio Tankers Inc. (NYSE: STNG) traded down about 2.6% Monday and posted a new 52-week low of $1.85 after closing Friday at $1.90. The stock’s 52-week high is $4.18. Volume was about equal to the daily average of around 3.4 million. The company had no specific news., and shares are on their way to closing up about 9% for the day.

Top 10 Medical Stocks To Buy Right Now: R.R. Donnelley & Sons Company(RRD)

Advisors' Opinion:

• [By Nicholas Rossolillo]

  While true in theory, many stocks with high yields are high-yielding for a reason: They are also high risk. What seemed like easy money could end up having the opposite of the desired effect. With that in mind, here are three stocks that look like yield traps to me: Pitney Bowes (NYSE:PBI), R.R. Donnelley & Sons (NYSE:RRD), and Teekay Tankers (NYSE:TNK).

• [By Joseph Griffin]

  RR Donnelley (NYSE:RRD) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Wednesday.

• [By Max Byerly]

  Sei Investments Co. raised its stake in RR Donnelley & Sons Co (NYSE:RRD) by 51.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,150 shares of the business services provider’s stock after acquiring an additional 8,847 shares during the period. Sei Investments Co.’s holdings in RR Donnelley & Sons were worth $229,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Buy Right Now: Nabors Industries Ltd.(NBR)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Nabors Industries (NBR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Niobio Cash (CURRENCY:NBR) traded 16.4% higher against the dollar during the twenty-four hour period ending at 20:00 PM ET on August 16th. Niobio Cash has a market cap of $195,546.00 and $370.00 worth of Niobio Cash was traded on exchanges in the last 24 hours. One Niobio Cash coin can currently be bought for approximately $0.0018 or 0.00000029 BTC on major cryptocurrency exchanges including Crex24 and TradeOgre. During the last week, Niobio Cash has traded 2.2% higher against the dollar.

• [By Logan Wallace]

  Nabors Industries Ltd. (NYSE:NBR) gapped up prior to trading on Thursday . The stock had previously closed at $6.13, but opened at $6.27. Nabors Industries shares last traded at $6.29, with a volume of 6673544 shares changing hands.

• [By Ethan Ryder]

  Niobio Cash (CURRENCY:NBR) traded 0.6% lower against the US dollar during the 1-day period ending at 14:00 PM Eastern on October 7th. One Niobio Cash coin can now be purchased for approximately $0.0018 or 0.00000027 BTC on major exchanges including Crex24 and TradeOgre. Niobio Cash has a total market capitalization of $194,367.00 and $31.00 worth of Niobio Cash was traded on exchanges in the last day. Over the last seven days, Niobio Cash has traded 12.7% lower against the US dollar.

Top 10 Medical Stocks To Buy Right Now: Thor Industries Inc.(THO)

Advisors' Opinion:

• [By Shane Hupp]

  Brokerages expect Tahoe Resources Inc (NYSE:TAHO) (TSE:THO) to announce earnings of $0.02 per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Tahoe Resources’ earnings. The highest EPS estimate is $0.04 and the lowest is ($0.01). Tahoe Resources reported earnings per share of $0.11 in the same quarter last year, which would suggest a negative year over year growth rate of 81.8%. The company is scheduled to issue its next quarterly earnings results on Tuesday, August 14th.

• [By Ethan Ryder]

  Thor Industries, Inc. (NYSE:THO) – Northcoast Research decreased their Q1 2019 EPS estimates for shares of Thor Industries in a report issued on Thursday, September 20th. Northcoast Research analyst S. Woolf now anticipates that the construction company will earn $1.39 per share for the quarter, down from their previous forecast of $1.52. Northcoast Research currently has a “Buy” rating on the stock. Northcoast Research also issued estimates for Thor Industries’ Q3 2019 earnings at $2.20 EPS, Q1 2020 earnings at $1.85 EPS, Q2 2020 earnings at $1.87 EPS, Q3 2020 earnings at $2.65 EPS and Q4 2020 earnings at $2.14 EPS.

• [By Logan Wallace]

  Northcoast Research reaffirmed their buy rating on shares of Thor Industries (NYSE:THO) in a research note published on Friday morning.

  Other research analysts also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Thor Industries from a sell rating to a hold rating in a report on Friday. ValuEngine downgraded shares of Thor Industries from a hold rating to a sell rating in a report on Saturday, May 12th. BMO Capital Markets upgraded shares of Thor Industries from a market perform rating to an outperform rating and set a $102.00 price objective on the stock in a report on Tuesday, May 1st. Sidoti dropped their price objective on shares of Thor Industries from $148.00 to $144.00 and set a buy rating on the stock in a report on Friday, August 10th. Finally, Citigroup dropped their price objective on shares of Thor Industries from $150.00 to $130.00 and set a buy rating on the stock in a report on Thursday, June 21st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the company’s stock. Thor Industries currently has a consensus rating of Buy and a consensus target price of $128.50.

• [By Steve Symington]

  Shares of Thor Industries Inc. (NYSE:THO) were down 12.8% as of 3:15 p.m. EDT Thursday after the recreational-vehicle specialist announced weaker-than-expected fiscal fourth-quarter 2018 earnings.

Top 10 Medical Stocks To Buy Right Now: Rockwell Automation, Inc.(ROK)

Advisors' Opinion:

• [By Lee Samaha]

  Stock in process automation company Rockwell Automation (NYSE:ROK) bounced nicely after its recent third-quarter results and gave investors hope it could have a much better second half than its first. Let's take a look at what's gone on with the company in 2018, and why there's cause for optimism going forward.

• [By Lee Samaha]

  Similarly, in a bold and audacious step, Farr made a bid to buy Rockwell Automation (NYSE:ROK) for $225 a share (the price at this writing is around $172), though it ultimately failed. The idea was to add Emerson's strength in process automation (fluid materials process in heavy industries) to Rockwell's discrete automation (automated processes in manufacturing) while adding Rockwell's capability with programmable logic controllers (PLCs) -- a market dominated by Siemens and Rockwell.

• [By Lisa Levin] Companies Reporting Before The Bell Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion. Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion. Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million. Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion. General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion. The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion. Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion. Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion. Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion. Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion. Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion. The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion. Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion. T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion. Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion. Sirius XM Holdings Inc. (NASDAQ: SI
• [By Lee Samaha]

  Having already looked at some of the positive recommendations from Morgan Stanley, it's time to examine whether its two negative ratings, for Rockwell Automation (NYSE:ROK) and Lennox International (NYSE:LII), are worth selling.

• [By Lee Samaha]

  Investing in robotics is a popular idea, but sometimes you have to dig a bit deeper to find stocks exposed to the theme. In this context, I think Cognex Corporation's (NASDAQ:CGNX) machine vision solutions, Rockwell Automation Inc.'s (NYSE:ROK) industrial automation technology, and NICE Ltd.'s (NASDAQ:NICE) data analytics and artificial intelligence (AI) are well suited to profit from increased spending on robotics. Let's look at the case for each of the three.

Top 10 Medical Stocks To Buy Right Now: iShares Morningstar Large-Cap Growth (JKE)

Advisors' Opinion:

• [By Joseph Griffin]

  iShares Morningstar Large Growth (NYSEARCA:JKE) declared a quarterly dividend on Tuesday, June 26th, Wall Street Journal reports. Investors of record on Wednesday, June 27th will be paid a dividend of 0.3796 per share on Monday, July 2nd. This represents a $1.52 annualized dividend and a yield of 0.87%. The ex-dividend date is Tuesday, June 26th. This is a boost from iShares Morningstar Large Growth’s previous quarterly dividend of $0.34.

• [By Ethan Ryder]

  iShares Morningstar Large-Cap Growth ETF (NYSEARCA:JKE) declared a quarterly dividend on Thursday, September 27th, Wall Street Journal reports. Investors of record on Thursday, September 27th will be paid a dividend of 0.2522 per share on Tuesday, October 2nd. This represents a $1.01 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date is Wednesday, September 26th.

Top 10 Medical Stocks To Buy Right Now: Just Energy Group, Inc.(JE)

Advisors' Opinion:

• [By Shane Hupp]

  Just Energy Group Inc (NYSE:JE) (TSE:JE) has been assigned a consensus recommendation of “Buy” from the ten analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $6.53.

• [By Stephan Byrd]

  Shares of Just Eat PLC (LON:JE) have earned a consensus recommendation of “Buy” from the sixteen brokerages that are presently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is GBX 844.62 ($11.33).

• [By Max Byerly]

  Just Energy Group Inc (NYSE:JE) (TSE:JE) has received a consensus rating of “Hold” from the eleven ratings firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $5.78.

Top 10 Medical Stocks To Buy Right Now: Liberty All-Star Equity Fund(USA)

Advisors' Opinion:

• [By ]

  Given that the Fed has indicated it would welcome a modest overshoot in inflation, markets would likely need to see wages grow by 0.4 percent or 0.5 percent to gain confidence in a fourth 2018 hike, according to Priya Misra, head of global rates strategy at TD Securities (USA) LLC.

• [By ]

  These are the participating banks:

  In the U.S.: Ally Financial, American Express, Bank of America, Bank of New York Mellon, BB&T, Capital One, CIT, Citigroup, Citizens Financial, Comerica, Discover Financial, Fifth Third, Goldman Sachs, Huntington, JPMorgan Chase, KeyBanc, M&T, Morgan Stanley, Northern Trust, PNC Financial, Regions Financial, State Street, SunTrust, U.S. Bancorp, Wells Fargo, and Zions. Non-U.S. firms: Barclays US, BBVA Compass Bancshares, BMO Financial, BNP Paribas USA, Credit Suisse Holdings (USA), Deutsche Bank USA, HSBC North America Holdings, MUFG Americas Holdings, RBC USA, Santander Holdings USA, TD Group US, UBS Americas

  Here’s a sample of recent analyst commentary:

Top 10 Medical Stocks To Buy Right Now: Nemaska Lithium Inc. (NMKEF)

Advisors' Opinion:

• [By ]

  Nemaska Lithium (OTCQX:NMKEF) is a company that has been at the top of my radar over the past few months. It has successfully raised in excess of $500 million in capital to support the build-out of vertically integrated operations in Quebec. The company is undertaking a significant effort to become one of the few fully-integrated lithium companies in existence, with operations from mining to chemical production.

• [By ]

  I recently finished putting together the Lithium subsector index of my Industrial Minefinder™ Junior Index (IMJI). To start out, the IMJI Lithium subsector will include 4 companies and comprise 8% of the overall IMJI index, which will include 50 companies in all. Here is a table that shows the holdings:

  Company Market Cap
  ($USD millions;
  as of Jan 2, 2018) Contained
  Lithium Carbonate Equivalent (LCE) in Total Resource
  (tonnes) Index
  Weighting Kidman Resources (OTCPK:KDDRF) $596 7,010,955 23% Lithium Americas (OTC:LAC) $809 39,287,234 32% Millennial Lithium (OTCQX:MLNLF) $308 3,009,000 12% Nemaska Lithium (OTCQX:NMKEF) $835 1,593,802 33% $2,548 100%

  The following 6 companies are on the bench for the index:

• [By ]

  In April 2018, Nemaska (OTCQX:NMKEF) drew nearly $100 million in investment from Japan's SoftBank (OTCPK:SFTBY) group in exchange for a 9.9% interest in the company and access to lithium hydroxide produced by the company. In March 2018, CATL the world's soon-to-be largest lithium battery manufacturer purchased a controlling stake in the Quebec Lithium project in consideration for $66 million. In February 2018, Korean steel giant, POSCO (PKX) announced a supply agreement and investment into Australian lithium miner Pilbara Minerals (OTCPK:PILBF). In January 2018, Toyota Tsusho (OTCPK:TYHOF), the strategic trading arm of Toyota Motors, invested approximately A$300 million in Orocobre (OTCPK:OROCF) in consideration for 15% of the company. Now, in April 2018, Swedish battery start-up NorthVolt has announced that it has signed an agreement for the supply of up to 5,000 metric tons per year of lithium hydroxide produced at Nemaska Lithium's commercial plant in Shawinigan, Quebec. In connection with the supply of lithium chemicals, NorthVolt has agreed to deliver to Nemaska a 10 million euro promissory note that can be converted into voting shares of NorthVolt.

• [By ]

  Canadian hard-rock lithium chemicals company Nemaska Lithium (OTCQX:NMKEF) is presently at the end of completing a $500 million capital raise which will allow the company to expand into Phase 2 production of the its facility in Quebec. The company has closed an equity deal valued at nearly $100 million from Japan's SoftBank (OTCPK:SFTBY), executed a streaming agreement with Orion Mine Finance LF valued at over $150 million, and engaged with such high-quality financial groups including Clarkson Platou Securities and Pareto Securities as managers of the bond issuance. Further, Nemaska has signed multiple offtake agreements, including NorthVolt, FMC, Softbank and Johnson Matthey Battery Materials, for the purchase of its lithium chemicals once production begins.

• [By ]

  Other juniors include: Advantage Lithium (OTCQB:AVLIF) [TSXV:AAL], AIS Resources [TSXV:AIS] (OTCQB:AISSF), American Lithium Corp. [TSX-V: LI] (OTCQB:LIACF), Argentina Lithium and Energy Corp. [TSXV:LIT] (OTCQB:PNXLF), Argosy Minerals [ASX:AGY] (OTC:ARYMF), AVZ Minerals [ASX:AVZ] (OTC:AZZVF), Bacanora Minerals [TSXV:BCN] [AIM:BCN] [GR:1BQ] (OTC:BCRMF), Birimian Ltd [ASX:BGS] (OTC:EEYMF), Critical Elements [TSXV:CRE] [GR:F12] (OTCQX:CRECF), Dajin Resources [TSXV:DJI] (OTCPK:DJIFF), Enigri (private), Eramet (EN Paris:ERA) (OTCPK:ERMAY), European Metals Holdings [ASX:EMH] [AIM:EMH] [GR:E861] (OTC:ERPNF), Far Resources [CSE:FAT] (OTCPK:FRRSF), Force Commodities [ASX:4CE], Kidman Resources [ASX:KDR] [GR:6KR], Latin Resources Ltd [ASX: LRS] (OTC:LAXXF), Lithium Australia [ASX:LIT] (OTC:LMMFF), Lithium Power International [ASX:LPI] (OTC:LTHHF), LSC Lithium [TSXV:LSC] (OTC:LSSCF), MetalsTech [ASX:MTC], MGX Minerals [CSE:XMG] (OTC:MGXMF), Millennial Lithium Corp. [TSXV:ML] (OTCQB:MLNLF), Neo Lithium [TSXV:NLC] (OTC:NTTHF), NRG Metals Inc. [TSXV:NGZ] (OTCQB:NRGMF), Nemaska Lithium [TSX:NMX] [GR:NOT] (OTCQX:NMKEF), North American Lithium (private), Piedmont Lithium [ASX:PLL] (OTC:PLLLY), Prospect Resources [ASX:PSC], Sayona Mining [ASX:SYA] (OTCPK:DMNXF), Savannah Resources [LSE:SAV], Standard Lithium [TSXV:SLL] (OTC:STLHF), and Wealth Minerals [TSXV:WML] (OTCQB:WMLLF).

• [By ]

  Over the past two months, Nemaska Lithium (OTCQX:NMKEF) has steadily been updating the market on its half-billion-dollar-plus financial raise. The company has aggressively set targets to build out a vertically integrated lithium mining and processing operation ideally positioned to meet growing demand in North America and Europe.

Top 10 Medical Stocks To Buy Right Now: Ambarella, Inc.(AMBA)

Advisors' Opinion:

• [By Motley Fool Staff]

  Ambarella (NASDAQ:AMBA) Q1 2019 Earnings Conference CallJun. 5, 2018 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Harsh Chauhan]

  Investors' enthusiasm for Ambarella (NASDAQ:AMBA) came crashing down after the video-processing-chip specialist's fiscal first-quarter performance didn't do much to dispel fears that it was finding it difficult to grow despite operating in verticals that promise a lot of opportunities.

• [By Chris Lange]

  Ambarella Inc. (NASDAQ: AMBA) is expected to report its fiscal first-quarter results on Tuesday. The analysts' consensus forecast is EPS of $0.09 on $56.14 million in revenue. Shares were changing hands at $49.15 as last week came to a close. The consensus price target is $59.38, and the stock has a 52-week range of $40.06 to $66.23.

• [By Steve Symington]

  Shares of Ambarella Inc. (NASDAQ:AMBA) were down 12.8% as of 2:30 p.m. EDT Wednesday after the video-processing chip specialist announced solid fiscal first-quarter 2019 results, but followed with disappointing forward guidance.

• [By Leo Sun]

  Intel's acquisition of Movidius caused serious headaches for Ambarella (NASDAQ:AMBA), which sells image processing SoCs for action cameras, dash cams, security cameras, and drones. Movidius' Myriad 2 VPUs bundled together image processing, computer vision, and machine learning capabilities, which left Ambarella's SoCs behind a crucical tech curve.